Jefferies analyst Faisal Khurshid downgraded Abivax (NASDAQ: ABVX) from Buy to Hold with a price target of $90.00 (from $160.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE